XML 23 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Marketable Securities
6 Months Ended
Jun. 30, 2025
Debt Securities, Available-for-Sale [Abstract]  
Marketable Securities

7. Marketable Securities

Rambus invests its excess cash and cash equivalents primarily in U.S. government-sponsored obligations, non-U.S. government-sponsored obligations, corporate bonds, commercial paper and notes, time deposits and money market funds that mature within three years.

All cash equivalents and marketable securities are classified as available-for-sale. Total cash, cash equivalents and marketable securities are summarized as follows:

 

 

As of June 30, 2025

 

(In thousands)

 

Fair Value

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

Cash

 

$

59,029

 

 

$

59,029

 

 

$

 

 

$

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

14,297

 

 

 

14,297

 

 

 

 

 

 

 

Corporate bonds, commercial paper and notes

 

 

14,433

 

 

 

14,438

 

 

 

 

 

 

(5

)

Total cash equivalents

 

 

28,730

 

 

 

28,735

 

 

 

 

 

 

(5

)

Total cash and cash equivalents

 

 

87,759

 

 

 

87,764

 

 

 

 

 

 

(5

)

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Time deposits

 

 

12,870

 

 

 

12,870

 

 

 

 

 

 

 

U.S. Government bonds and notes

 

 

202,535

 

 

 

202,530

 

 

 

94

 

 

 

(89

)

Non-U.S. Government bonds and notes

 

 

3,947

 

 

 

3,946

 

 

 

1

 

 

 

 

Corporate bonds, commercial paper and notes

 

 

287,714

 

 

 

287,707

 

 

 

133

 

 

 

(126

)

Total marketable securities

 

 

507,066

 

 

 

507,053

 

 

 

228

 

 

 

(215

)

Total cash, cash equivalents and marketable securities

 

$

594,825

 

 

$

594,817

 

 

$

228

 

 

$

(220

)

 

 

As of December 31, 2024

 

(In thousands)

 

Fair Value

 

 

Amortized
Cost

 

 

Gross
Unrealized
Gains

 

 

Gross
Unrealized
Losses

 

Cash

 

$

87,415

 

 

$

87,415

 

 

$

 

 

$

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

6,025

 

 

 

6,025

 

 

 

 

 

 

 

Corporate bonds, commercial paper and notes

 

 

6,335

 

 

 

6,334

 

 

 

1

 

 

 

 

Total cash equivalents

 

 

12,360

 

 

 

12,359

 

 

 

1

 

 

 

 

Total cash and cash equivalents

 

 

99,775

 

 

 

99,774

 

 

 

1

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Time deposits

 

 

12,870

 

 

 

12,870

 

 

 

 

 

 

 

U.S. Government bonds and notes

 

 

220,056

 

 

 

220,034

 

 

 

184

 

 

 

(162

)

Corporate bonds, commercial paper and notes

 

 

149,097

 

 

 

149,085

 

 

 

121

 

 

 

(109

)

Total marketable securities

 

 

382,023

 

 

 

381,989

 

 

 

305

 

 

 

(271

)

Total cash, cash equivalents and marketable securities

 

$

481,798

 

 

$

481,763

 

 

$

306

 

 

$

(271

)

 

Available-for-sale securities are reported at fair value on the balance sheets and classified along with cash as follows:

 

 

As of

 

(In thousands)

 

June 30, 2025

 

 

December 31, 2024

 

Cash

 

$

59,029

 

 

$

87,415

 

Cash equivalents

 

 

28,730

 

 

 

12,360

 

Total cash and cash equivalents

 

 

87,759

 

 

 

99,775

 

Marketable securities

 

 

507,066

 

 

 

382,023

 

Total cash, cash equivalents and marketable securities

 

$

594,825

 

 

$

481,798

 

 

 

The Company continues to invest in highly rated, liquid debt securities. The Company holds all of its marketable securities as available-for-sale, marks them to market, and regularly reviews its portfolio to ensure adherence to its investment policy and to monitor individual investments for risk analysis, proper valuation, and impairment.

The estimated fair value and gross unrealized losses of cash equivalents and marketable securities classified by the length of time that the securities have been in a continuous unrealized loss position as of June 30, 2025 and December 31, 2024 were as follows:

 

 

Fair Value

 

 

Gross Unrealized Losses

 

(In thousands)

 

June 30,
2025

 

 

December 31,
2024

 

 

June 30,
2025

 

 

December 31,
2024

 

Less than 12 months

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government bonds and notes

 

$

97,475

 

 

$

83,162

 

 

$

(89

)

 

$

(162

)

Corporate bonds, commercial paper and notes

 

 

217,515

 

 

 

48,360

 

 

 

(131

)

 

 

(109

)

Total cash equivalents and marketable securities in a continuous unrealized loss position

 

$

314,990

 

 

$

131,522

 

 

$

(220

)

 

$

(271

)

 

The gross unrealized losses as of June 30, 2025 and December 31, 2024 were not material in relation to the Company’s total available-for-sale portfolio. The gross unrealized losses can be primarily attributed to a combination of market conditions, as well as the demand for and duration of the U.S. government-sponsored obligations and corporate bonds, commercial paper and notes. The Company reasonably believes that there is no need to sell these investments and that it can recover the amortized cost of these investments. The Company has found no evidence of impairment due to credit losses in its portfolio. Therefore, these unrealized losses were recorded in other comprehensive income (loss). The Company cannot provide any assurance that its portfolio of cash, cash equivalents and marketable securities will not be impacted by adverse conditions in the financial markets, which may require the Company in the future to record an impairment charge for credit losses which could adversely impact its financial results.

The contractual maturities of cash equivalents (excluding money market funds which have no maturity) and marketable securities are summarized as follows:

 

(In thousands)

 

June 30, 2025

 

Due in less than one year

 

$

418,498

 

Due from one year through three years

 

 

103,001

 

Total

 

$

521,499

 

 

Refer to Note 8, “Fair Value of Financial Instruments,” for a discussion regarding the fair value of the Company’s cash equivalents and marketable securities.